increased anxiety on glp 1 GLP-1 medications used to treat diabetes and obesity may also help alleviate symptoms of and depression An analysis on the role

Many patients assume these medications are out of reach or do not know their plan may cover them

The SDUD are updated quarterly

Graphic by Clara Turnage/University Marketing and Communications For patients whose insurance wont cover GLP-1 medications, lower-cost compounded versions can seem like an attractive alternative, but the researchers urge caution

investigated the impact of liraglutide 3 mg in 14 obese patients with HS, finding significant reductions in BMI, waist circumference, CRP, homocysteine, and plasma cortisol after 3 months treatment

But insurance companies want to keep costs down themselves, so many won't cover them for weight loss, or require patients to jump through frustrating hoops to get approval for coverage

The solution: Consider breaks after 12 to 16 weeks of use, or experiment with dosage cycles